-
Dec 16, 2024, 08:12 AM
by
BC Platforms, a global leader in real-world data, healthcare data management, and analytics, has announced an extended, joint partnership with the University of Nottingham (UoN) and Nottingham University Hospitals NHS Trust (NUH) to provide data-sharing platforms and tools facilitating data sharing, security, and advanced analyses including Trusted Research Environments (TREs*). The outputs of analysing such data, from both clinical and basic research, have the potential to transform our understanding of important healthcare trends, as well as studying devastating diseases such as cancer and diabetes up to the population level. They could also potentially help unlock innovative new solutions and therapies for patients everywhere.
Full story
-
Dec 13, 2024, 07:55 AM
by
VieCure announced Commonwealth Cancer Center will deploy its Halo Intelligence platform - the first AI-enabled community oncology care solution. Clinicians will use the platform to manage precision oncology data and help determine the optimal personalized treatment path for patients across rural Kentucky.
Full story
-
Dec 13, 2024, 07:55 AM
by
Coronado Research announced today that Dr Jennifer Bradford has been appointed as VP, Head of Data Science.
Full story
-
Dec 13, 2024, 01:00 AM
by
User Not Found
Bio-IT World | Japan has long taken a leadership role in the pursuit of boron neutron capture therapy (BNCT) as a treatment for cancer. The approach involves injecting patients with a boron-containing compound that accumulates in tumor cells and acts as an exclusive target for neutrons to kill and was the research focus of a pair of Harvard scientists throughout the 1950s.
Full story
-
Dec 12, 2024, 08:05 AM
by
Full story
-
Dec 11, 2024, 08:05 AM
by
Indica Labs today announces that the Institute of Tissue Medicine and Pathology at the University of Bern has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc.
Full story
-
Dec 11, 2024, 08:05 AM
by
Full story
-
Dec 11, 2024, 08:05 AM
by
ZeOmega®, the leading population health management organization, today announced that it was recognized as a Major Player in the IDC MarketScape: U.S. Health Plan Prior Authorization Solutions 2024 Vendor Assessment (doc #US51810824, November 2024) report. ZeOmega believes this distinction reflects its innovative use of AI and other technologies to optimize prior authorization processes and meet interoperability standards, empowering health plans to improve provider satisfaction and member outcomes with faster, more efficient approvals.
Full story
-
Dec 11, 2024, 01:00 AM
by
User Not Found
Bio-IT World | An intriguing new study suggests that the people we interact with socially influence the bacteria populating our gut. The implication is that some diseases considered nontransmissible may have a component that makes them contagious.
Full story
-
Dec 10, 2024, 05:40 AM
by
Sapio Sciences, the science-aware™ lab informatics platform, today announced that evitria, a leader in antibody expression services, has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities.
Full story
-
Dec 10, 2024, 05:40 AM
by
Full story
-
Dec 10, 2024, 05:40 AM
by
The first AI-driven assistant of its kind in the preclinical oncology space, CertisOI Assistant enables users to query vast datasets, perform complex computational analyses, and visualize drug efficacy predictions—all through a seamless, natural language interface. With this solution, Certis is redefining how researchers interact with oncology data, promising to accelerate the development of new cancer therapies and the realization of personalized medicine. Highly specialized for oncology research, CertisOI Assistant’s conversational interface and integration with CertisAI, Certis’ proprietary AI/ML platform allow cancer scientists to easily query both public and proprietary tumor model datasets; perform complex ad hoc analyses; convert results into downloadable tables, charts, and graphs for actionable insights, and leverage AI-generated drug response predictions to inform critical research decisions.
Full story
-
Dec 10, 2024, 05:40 AM
by
DNAnexus and Panomics to Deliver Multi-omics Data Solutions for Biopharma
Full story
-
Dec 10, 2024, 05:40 AM
by
Phastar, a global specialist biometrics contract research organization (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards.
Full story
-
Dec 10, 2024, 01:00 AM
by
User Not Found
Bio-IT World | A project to study the genomes of living organisms in the Arctic region, known as “A Thousand Arctic Genomes,” has been launched in Russia. As part of the project, scientists will create genetic data banks and perform whole-genome sequencing of Arctic inhabitants in order to assess biodiversity and use the data obtained to preserve it.
Full story
-
Dec 9, 2024, 08:07 AM
by
Oxford Nanopore Technologies announced a new collaboration with UK Biobank to create the world’s first comprehensive, large-scale epigenetic dataset.
Full story
-
Dec 9, 2024, 08:06 AM
by
Intelliguard, a provider of medication management and data-intelligence solutions, announces a strategic partnership with Codonics, a global leader in healthcare technology offering cutting-edge solutions for patient safety. This partnership allows Intelliguard’s Mira Care Station customers to leverage the Codonics Safe Label System (SLS) for fast, compliant, and standardized syringe labeling, ensuring a closed-loop medication process in operating rooms.
Full story
-
Dec 6, 2024, 07:12 AM
by
Proscia also ranks as the top vendor in diagnostic digital pathology market landscapes.
Full story
-
Dec 5, 2024, 07:35 AM
by
KELES, venture capital firm led by digital health investors David Buller and Laurent Van Lerberghe, appoints three expert advisors to strengthen its leadership team and accelerate progress in European digital health innovation.
Full story
-
Dec 5, 2024, 01:00 AM
by
User Not Found
Bio-IT World | It sounds too good to be true: a nasal spray that delays Alzheimer’s-related behavioral and cognitive problems a decade or more after initial diagnosis. But promising first steps in that direction have already been taken using “therapeutic EVs” (extracellular vesicles) restricting the activation of inflammatory cytokines in the brain of mice.
Full story